img

Global Blastomycosis Treatment Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Blastomycosis Treatment Market Research Report 2024

Most people will need antifungal treatment for blastomycosis. Most people with blastomycosis will need treatment with prescription antifungal medication. Itraconazole is a type of antifungal medication that is typically used to treat mild to moderate blastomycosis.
According to Mr Accuracy reports new survey, global Blastomycosis Treatment market is projected to reach US$ 269.2 million in 2029, increasing from US$ 178 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Blastomycosis Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Blastomycosis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Emcure Pharmaceuticals
Viatris
Hindustan Antibiotics Limited
Sun Pharmaceutical Industries Ltd.
Novartis
Sanofi
Merck & Co
Segment by Type
Itraconazole
Amphotericin B
Others

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Blastomycosis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blastomycosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Itraconazole
1.2.3 Amphotericin B
1.2.4 Others
1.3 Market by Application
1.3.1 Global Blastomycosis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blastomycosis Treatment Market Perspective (2018-2029)
2.2 Blastomycosis Treatment Growth Trends by Region
2.2.1 Global Blastomycosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Blastomycosis Treatment Historic Market Size by Region (2018-2024)
2.2.3 Blastomycosis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Blastomycosis Treatment Market Dynamics
2.3.1 Blastomycosis Treatment Industry Trends
2.3.2 Blastomycosis Treatment Market Drivers
2.3.3 Blastomycosis Treatment Market Challenges
2.3.4 Blastomycosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blastomycosis Treatment Players by Revenue
3.1.1 Global Top Blastomycosis Treatment Players by Revenue (2018-2024)
3.1.2 Global Blastomycosis Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Blastomycosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blastomycosis Treatment Revenue
3.4 Global Blastomycosis Treatment Market Concentration Ratio
3.4.1 Global Blastomycosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blastomycosis Treatment Revenue in 2022
3.5 Blastomycosis Treatment Key Players Head office and Area Served
3.6 Key Players Blastomycosis Treatment Product Solution and Service
3.7 Date of Enter into Blastomycosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blastomycosis Treatment Breakdown Data by Type
4.1 Global Blastomycosis Treatment Historic Market Size by Type (2018-2024)
4.2 Global Blastomycosis Treatment Forecasted Market Size by Type (2024-2029)
5 Blastomycosis Treatment Breakdown Data by Application
5.1 Global Blastomycosis Treatment Historic Market Size by Application (2018-2024)
5.2 Global Blastomycosis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Blastomycosis Treatment Market Size (2018-2029)
6.2 North America Blastomycosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Blastomycosis Treatment Market Size by Country (2018-2024)
6.4 North America Blastomycosis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blastomycosis Treatment Market Size (2018-2029)
7.2 Europe Blastomycosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Blastomycosis Treatment Market Size by Country (2018-2024)
7.4 Europe Blastomycosis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blastomycosis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Blastomycosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Blastomycosis Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Blastomycosis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blastomycosis Treatment Market Size (2018-2029)
9.2 Latin America Blastomycosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Blastomycosis Treatment Market Size by Country (2018-2024)
9.4 Latin America Blastomycosis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blastomycosis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Blastomycosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Blastomycosis Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Blastomycosis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emcure Pharmaceuticals
11.1.1 Emcure Pharmaceuticals Company Detail
11.1.2 Emcure Pharmaceuticals Business Overview
11.1.3 Emcure Pharmaceuticals Blastomycosis Treatment Introduction
11.1.4 Emcure Pharmaceuticals Revenue in Blastomycosis Treatment Business (2018-2024)
11.1.5 Emcure Pharmaceuticals Recent Development
11.2 Viatris
11.2.1 Viatris Company Detail
11.2.2 Viatris Business Overview
11.2.3 Viatris Blastomycosis Treatment Introduction
11.2.4 Viatris Revenue in Blastomycosis Treatment Business (2018-2024)
11.2.5 Viatris Recent Development
11.3 Hindustan Antibiotics Limited
11.3.1 Hindustan Antibiotics Limited Company Detail
11.3.2 Hindustan Antibiotics Limited Business Overview
11.3.3 Hindustan Antibiotics Limited Blastomycosis Treatment Introduction
11.3.4 Hindustan Antibiotics Limited Revenue in Blastomycosis Treatment Business (2018-2024)
11.3.5 Hindustan Antibiotics Limited Recent Development
11.4 Sun Pharmaceutical Industries Ltd.
11.4.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.4.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.4.3 Sun Pharmaceutical Industries Ltd. Blastomycosis Treatment Introduction
11.4.4 Sun Pharmaceutical Industries Ltd. Revenue in Blastomycosis Treatment Business (2018-2024)
11.4.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Blastomycosis Treatment Introduction
11.5.4 Novartis Revenue in Blastomycosis Treatment Business (2018-2024)
11.5.5 Novartis Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Blastomycosis Treatment Introduction
11.6.4 Sanofi Revenue in Blastomycosis Treatment Business (2018-2024)
11.6.5 Sanofi Recent Development
11.7 Merck & Co
11.7.1 Merck & Co Company Detail
11.7.2 Merck & Co Business Overview
11.7.3 Merck & Co Blastomycosis Treatment Introduction
11.7.4 Merck & Co Revenue in Blastomycosis Treatment Business (2018-2024)
11.7.5 Merck & Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Blastomycosis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Itraconazole
Table 3. Key Players of Amphotericin B
Table 4. Key Players of Others
Table 5. Global Blastomycosis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Blastomycosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Blastomycosis Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Blastomycosis Treatment Market Share by Region (2018-2024)
Table 9. Global Blastomycosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Blastomycosis Treatment Market Share by Region (2024-2029)
Table 11. Blastomycosis Treatment Market Trends
Table 12. Blastomycosis Treatment Market Drivers
Table 13. Blastomycosis Treatment Market Challenges
Table 14. Blastomycosis Treatment Market Restraints
Table 15. Global Blastomycosis Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Blastomycosis Treatment Market Share by Players (2018-2024)
Table 17. Global Top Blastomycosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blastomycosis Treatment as of 2022)
Table 18. Ranking of Global Top Blastomycosis Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Blastomycosis Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Blastomycosis Treatment Product Solution and Service
Table 22. Date of Enter into Blastomycosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Blastomycosis Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Blastomycosis Treatment Revenue Market Share by Type (2018-2024)
Table 26. Global Blastomycosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Blastomycosis Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Blastomycosis Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Blastomycosis Treatment Revenue Market Share by Application (2018-2024)
Table 30. Global Blastomycosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Blastomycosis Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Blastomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Blastomycosis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Blastomycosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Blastomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Blastomycosis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Blastomycosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Blastomycosis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Blastomycosis Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Blastomycosis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Blastomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Blastomycosis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Blastomycosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Blastomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Blastomycosis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Blastomycosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Emcure Pharmaceuticals Company Detail
Table 48. Emcure Pharmaceuticals Business Overview
Table 49. Emcure Pharmaceuticals Blastomycosis Treatment Product
Table 50. Emcure Pharmaceuticals Revenue in Blastomycosis Treatment Business (2018-2024) & (US$ Million)
Table 51. Emcure Pharmaceuticals Recent Development
Table 52. Viatris Company Detail
Table 53. Viatris Business Overview
Table 54. Viatris Blastomycosis Treatment Product
Table 55. Viatris Revenue in Blastomycosis Treatment Business (2018-2024) & (US$ Million)
Table 56. Viatris Recent Development
Table 57. Hindustan Antibiotics Limited Company Detail
Table 58. Hindustan Antibiotics Limited Business Overview
Table 59. Hindustan Antibiotics Limited Blastomycosis Treatment Product
Table 60. Hindustan Antibiotics Limited Revenue in Blastomycosis Treatment Business (2018-2024) & (US$ Million)
Table 61. Hindustan Antibiotics Limited Recent Development
Table 62. Sun Pharmaceutical Industries Ltd. Company Detail
Table 63. Sun Pharmaceutical Industries Ltd. Business Overview
Table 64. Sun Pharmaceutical Industries Ltd. Blastomycosis Treatment Product
Table 65. Sun Pharmaceutical Industries Ltd. Revenue in Blastomycosis Treatment Business (2018-2024) & (US$ Million)
Table 66. Sun Pharmaceutical Industries Ltd. Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Blastomycosis Treatment Product
Table 70. Novartis Revenue in Blastomycosis Treatment Business (2018-2024) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Sanofi Company Detail
Table 73. Sanofi Business Overview
Table 74. Sanofi Blastomycosis Treatment Product
Table 75. Sanofi Revenue in Blastomycosis Treatment Business (2018-2024) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Merck & Co Company Detail
Table 78. Merck & Co Business Overview
Table 79. Merck & Co Blastomycosis Treatment Product
Table 80. Merck & Co Revenue in Blastomycosis Treatment Business (2018-2024) & (US$ Million)
Table 81. Merck & Co Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blastomycosis Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Blastomycosis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Itraconazole Features
Figure 4. Amphotericin B Features
Figure 5. Others Features
Figure 6. Global Blastomycosis Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Blastomycosis Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Other Case Studies
Figure 11. Blastomycosis Treatment Report Years Considered
Figure 12. Global Blastomycosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Blastomycosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Blastomycosis Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Blastomycosis Treatment Market Share by Players in 2022
Figure 16. Global Top Blastomycosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blastomycosis Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Blastomycosis Treatment Revenue in 2022
Figure 18. North America Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Blastomycosis Treatment Market Share by Country (2018-2029)
Figure 20. United States Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Blastomycosis Treatment Market Share by Country (2018-2029)
Figure 24. Germany Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Blastomycosis Treatment Market Share by Region (2018-2029)
Figure 32. China Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Blastomycosis Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Blastomycosis Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Blastomycosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Emcure Pharmaceuticals Revenue Growth Rate in Blastomycosis Treatment Business (2018-2024)
Figure 47. Viatris Revenue Growth Rate in Blastomycosis Treatment Business (2018-2024)
Figure 48. Hindustan Antibiotics Limited Revenue Growth Rate in Blastomycosis Treatment Business (2018-2024)
Figure 49. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Blastomycosis Treatment Business (2018-2024)
Figure 50. Novartis Revenue Growth Rate in Blastomycosis Treatment Business (2018-2024)
Figure 51. Sanofi Revenue Growth Rate in Blastomycosis Treatment Business (2018-2024)
Figure 52. Merck & Co Revenue Growth Rate in Blastomycosis Treatment Business (2018-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries